Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea

Nutrition and Cancer

Volumn 48, Issue 1, 2004, Pages 44-53

  Liao, Jie ^a   Yang, Guang Yu ^a   Park, Eon Sub ^a   Meng, Xiaofeng ^a   Sun, Yuhai ^a   Jia, Dongxuan ^a   Seril, Darren N ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ANTIBODY; CD31 ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; FLUID INTAKE; FOOD INTAKE; IMMUNOHISTOCHEMISTRY; LUNG ADENOMA; LUNG CARCINOGENESIS; MOUSE; NICK END LABELING; NONHUMAN; TEA;

ANIMALIA; CAMELLIA; CAMELLIA SINENSIS;

EID: 3042595837     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4801_7     Document Type: Article

References (45)

1. Yang CS and Wang Z-Y: Tea and cancer. A review. JNCI 58, 1038-1049, 1993.
2. Yang CS, Maliakal P, and Meng X: Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42, 25-54, 2002.
3. Katiyar SK and Mukhtar H: Tea in chemoprevention of cancer: epidemiologic and experimental studies (review). Int J Oncol 8, 221-238, 1996.
4. Buschman JL: Green tea and cancer in humans: a review of the literature. Nutr Cancer 31, 151-159, 1998.
5. Xu Y, Ho C-T, Amin SG, Han C, and Chung F-L: Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res 52, 3875-3879, 1992.
6. Yang G, Wang ZY, Kim S, Liao J, Seril DN, et al.: Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice. Cancer Res 57, 1889-1894, 1997.
7. Yang G-Y, Liu Z, Seril DN, Liao J, Ding W, et al.: Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK)-induced lung tumorigenesis in A/J mice. Carcinogenesis 18, 2361-2365, 1997.
8. Yang GY, Liao J, Kim K, Yurkow EJ, and Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19, 611-616, 1998.
9. 2 production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 21, 2035-2039, 2000.
10. Yang CS and Chung JY: Growth inhibition of human cancer cell lines by tea polyphenols. Curr Pract Med 2, 163-166, 1999.
11. Chung JY, Huang C, Meng X, Dong Z, and Yang CS: Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res 59, 4610-4617, 1999.
12. McCarty MF: Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness. Med Hypotheses 50, 511-514, 1998.
13. Chung JY, Park JO, Phyu HP, Dong Z, and Yang CS: Mechanisms of inhibition of the ras-MAP kinase signaling pathway in 30.7b ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J 15, 2022-2024, 2001.
14. Ahmad N, Cheng P, and Mukhtar H: Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 275, 328-334, 2000.
15. Khafif A, Schantz SP, al-Rawi M, Edelstein D, and Sacks PG: Green tea regulates cell cycle progression in oral leukoplakia. Head Neck 20, 528-534, 1998.
16. Ahmad N, Gupta S, and Mukhtar H: Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys 376, 338-346, 2000.
17. Gupta S, Ahmad N, Nieminen AL, and Mukhtar H: Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 164, 82-90, 2000.
18. Dong Z, Ma W, Huang C, and Yang CS: Inhibition of tumor promoter-induced activator protein I activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 57, 4414-4419, 1997.
19. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, and Mukhtar H: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. JNCI 89, 1881-1886, 1997.
20. Hibasami H, Komiya T, Achiwa Y, Ohnishi K, Kojima T, et al.: Black tea theaflavins induce programmed cell death in cultured human stomach cancer cells. Int J Mol Med 1, 725-727, 1998.
21. Paschka AG, Butler R, and Young CY: Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130, 1-7, 1998.
22. Hibasami H, Komiya T, Achiwa Y, Ohnishi K, Kojima T, et al.: Induction of apoptosis in human stomach cancer cells by green tea catechins. Oncol Rep 5, 527-529, 1998.
23. Islam S, Islam N, Kermode T, Johnstone B, Mukhtar H, et al.: Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 270, 793-797, 2000.
24. Cao Y and Cao R: Angiogenesis inhibited by drinking tea [letter]. Nature 398, 381, 1999.
25. Bertolini F, Fusetti L, Rabascio C, Cinieri S, Martinelli G, et al.: Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia 14, 1477-1482, 2000.
26. Balentine DA, Wiseman SA, and Bouwens LC: The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37, 693-670, 1997.
27. Wang ZY, Hong J-Y, Huang M-T, and Reuhl KR: Inhibition of N-nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52, 1943-1947, 1992.
28. Hecht SS, Morse MA, Amin S, Stoner GD, Jordan KG, et al.: Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis 10, 1901-1904, 1989.
29. Lin J-M, Desai DH, Morse MA, Amin S, and Hecht SS: Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone pulmonary metabolism and tumorigenicity in mice by analogues of the investigational chemotherapeutic drug 4-ipomeanol. Chem Res Toxicol 5, 674-679, 1992.
30. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407, 249-257, 2000.
31. Kerbel RS: Tumor angiogenesis: past, present and the near future. Carcinogenesis 21, 505-515, 2000.
32. Gazdar AF and Minna JD: Angiogenesis and the multistage development of lung cancers [editorial; comment]. Clin Cancer Res 6, 1611-1612, 2000.
33. Gourley M and Williamson JS: Angiogenesis: new targets for the development of anticancer chemotherapies. Curr Pharm Des 6, 417-439, 2000.
34. Griffioen AW and Molema G: Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52, 237-268, 2000.
35. Tosetti F, Ferrari N, de Flora S, and Albini A: Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 16, 2-14, 2002.
36. Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, et al.: EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 23, 844-850, 2001.
37. Hong J-I, Smith TJ, Ho C-T, August DA, and Yang CS: Effect of purified green and black tea polyphenols on cyclooxygenase and lipoxygenase-dependent metabolism of arachidonic acid in the human colon mucosa and colon tumor tissues. Biochem Pharmcol 62, 1175-1183, 2001.
38. August DA, Landau J, Caputo D, Hong J, Lee MJ, et al.: Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomarkers Prev 8, 709-713, 1999.
39. Larrivee B and Karsan A: Signaling pathways induced by vascular endothelial growth factor (review). Int J Mol Med 5, 447-456, 2000.
40. Lamy S, Gingras D, and Bélivean R: Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 62, 381-385, 2002.
41. Lu Y-P, Lou Y-R, Li XH, Xie JG, Brash D, et al.: Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21 (WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res 60, 4785-4791, 2000.
42. Gupta S, Hastak K, Ahmad N, Lewin JS, and Mukhtar H.: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA, 98, 10350-10355, 2001.
43. Huang M-T, Xie J-G, Wang Z-Y, Ho C-T, Lou Y-R, et al.: Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res 57, 2623-2629, 1997.
44. Lu Y-P, Lou Y-R, Lin Y, Shih WJ, Huang M-T, Yang CS, and Conney AH: Inhibitory effects of orally administered green tea, black tea and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high risk mice): relationship to decreased tissue fat. Cancer Res 61, 5002-5009, 2001.
45. He Z, Ma W-Y, Hashimoto T, Bode AM, Yang CS, et al.: Induction of apoptosis by caffeine is mediated by the p53, Bax, and Caspase 3 pathways. Cancer Res 63, 4396-4401, 2003.